Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2018 | 1 |
2019 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis.
Thorac Cancer. 2023 Aug;14(22):2177-2186. doi: 10.1111/1759-7714.15004. Epub 2023 Jun 21.
Thorac Cancer. 2023.
PMID: 37340889
Free PMC article.
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer.
Schlick K, Markus S, Huemer F, Ratzinger L, Zaborsky N, Clemens H, Neureiter D, Neumayer B, Beate AS, Florian S, Martin V, Grundbichler M, Weiss L, Melchardt T, Greil R, Egle A.
Schlick K, et al. Among authors: ratzinger l.
Pancreatology. 2021 Dec;21(8):1466-1471. doi: 10.1016/j.pan.2021.09.004. Epub 2021 Sep 8.
Pancreatology. 2021.
PMID: 34511398
Free article.
Item in Clipboard
FGF5 is expressed in melanoma and enhances malignancy in vitro and in vivo.
Ghassemi S, Vejdovszky K, Sahin E, Ratzinger L, Schelch K, Mohr T, Peter-Vörösmarty B, Brankovic J, Lackner A, Leopoldi A, Meindl D, Pirker C, Hegedus B, Marian B, Holzmann K, Grasl-Kraupp B, Heffeter P, Berger W, Grusch M.
Ghassemi S, et al. Among authors: ratzinger l.
Oncotarget. 2017 Sep 23;8(50):87750-87762. doi: 10.18632/oncotarget.21184. eCollection 2017 Oct 20.
Oncotarget. 2017.
PMID: 29152117
Free PMC article.
Item in Clipboard
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients.
Schlick K, Magnes T, Huemer F, Ratzinger L, Weiss L, Pichler M, Melchardt T, Greil R, Egle A.
Schlick K, et al. Among authors: ratzinger l.
J Clin Med. 2019 Oct 25;8(11):1791. doi: 10.3390/jcm8111791.
J Clin Med. 2019.
PMID: 31717722
Free PMC article.
Item in Clipboard
Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
Schlick K, Magnes T, Ratzinger L, Jaud B, Weiss L, Melchardt T, Greil R, Egle A.
Schlick K, et al. Among authors: ratzinger l.
PLoS One. 2018 Nov 9;13(11):e0206688. doi: 10.1371/journal.pone.0206688. eCollection 2018.
PLoS One. 2018.
PMID: 30412592
Free PMC article.
Item in Clipboard
Cite
Cite